Butterfly Network (BFLY)
(Delayed Data from NYSE)
$0.99 USD
-0.01 (-0.51%)
Updated May 31, 2024 04:00 PM ET
After-Market: $0.99 0.00 (-0.49%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
BFLY 0.99 -0.01(-0.51%)
Will BFLY be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for BFLY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BFLY
Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner
5 Medical Info Systems Stocks to Buy for Stable Returns
BFLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging Butterfly Network (BFLY) This Year?
Butterfly Network, Inc. (BFLY) Reports Q4 Loss, Tops Revenue Estimates
Enovis (ENOV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Other News for BFLY
Nektar, Verastem among healthcare additions in Russell Microcap; Assertio, Sangamo removed
Butterfly Network to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference
Buy Rating Justified: Butterfly Network’s Growth Trajectory and Technological Edge
Buy Rating Affirmed: Butterfly Network’s Growth and Innovation with iQ+ Bladder Launch
Butterfly Network Enters the Bladder Scanning Market With First Specialty Product, iQ+ Bladder, in the United States